Clinical Trial Update: Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating CEA Positive Rectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update describing an early-stage therapeutic biological product mix for CEA-positive rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Therapeutic Biological Product Mix

Snippet

Sponsor: Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair | Conditions: Rectal Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING